organophosphonates has been researched along with Anogenital Type Verrucous Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleday, R; Fisher, DC; Mutyambizi, K; Nambudiri, VE; Saavedra, AP; Walls, AC | 1 |
| Gormley, RH; Kovarik, CL | 1 |
1 review(s) available for organophosphonates and Anogenital Type Verrucous Carcinoma
| Article | Year |
|---|---|
Human papillomavirus-related genital disease in the immunocompromised host: Part II.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts | 2012 |
1 other study(ies) available for organophosphonates and Anogenital Type Verrucous Carcinoma
| Article | Year |
|---|---|
Successful treatment of perianal giant condyloma acuminatum in an immunocompromised host with systemic interleukin 2 and topical cidofovir.
Topics: Administration, Topical; Antineoplastic Agents; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Cidofovir; Combined Modality Therapy; Cytosine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunocompromised Host; Interleukin-2; Male; Middle Aged; Neoplasm Recurrence, Local; Organophosphonates; Treatment Outcome | 2013 |